- CELG has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $469.6 million.
- CELG is down 2% today from today's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in CELG with the Ticky from Trade-Ideas. See the FREE profile for CELG NOW at Trade-Ideas More details on CELG: Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. CELG has a PE ratio of 41. Currently there are 13 analysts that rate Celgene a buy, no analysts rate it a sell, and 3 rate it a hold. The average volume for Celgene has been 4.8 million shares per day over the past 30 days. Celgene has a market cap of $94.2 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.91 and a short float of 1.8% with 3.19 days to cover. Shares are up 5.4% year-to-date as of the close of trading on Friday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.